EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies

Maosen Dou, Xue Zhang, Min Zhang iD

Journal of Inflammation Research · 2026-09 · Volume 19 · 1-17

DOI: 10.2147/jir.s632705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Maosen Dou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, …. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COPDasthmabiologicsbiomarkerstype 2 inflammation

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, People's Republic of China.

ORCID-Profile: Min Zhang

Zitieren

APA

Dou, M., Zhang, X., & Zhang, M. (2026). Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies. Journal of Inflammation Research, Volume 19, 1-17. https://doi.org/10.2147/jir.s632705

Vancouver

Dou M, Zhang X, Zhang M. Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies. Journal of Inflammation Research. 2026;Volume 19:1-17. doi:10.2147/jir.s632705

BibTeX
@article{Dou2026,
  author = {Dou, Maosen and Zhang, Xue and Zhang, Min},
  title = {Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--17},
  doi = {10.2147/jir.s632705}
}
Kostenlos starten →